Canada HEOR Lead: HTA, Pricing & Access

CA04 (FCRS = CA004) NOVARTIS PHARMA CANADA INC.; Toronto; Hybrid; CAD 122,000 - 169,000; Full time

Benefits offered by this job

Hybrid work options

Flexible hybrid working

Job summary

Novartis Canada is seeking a health economics and pricing expert to support country-level HTA, pricing and reimbursement strategies for Novartis brands in Canada. You will translate payer research into actionable insights and lead cross-functional submissions and negotiations to optimize patient access.

You will collaborate with Health Policy, Medical and international HEOR teams to develop listing agreements and evidence dossiers, ensuring timely listings and renewals. Hybrid Toronto location.

Qualifications

• Advanced education in health economics, epidemiology, biostatistics, outcomes research or a related discipline.
• Strong English communication skills and demonstrated experience in Canadian HTA and market access.
• Expertise in HTA evidence areas such as economic modelling, systematic reviews or indirect treatment comparisons.
• Experience developing or contributing to HTA strategies, evidence dossiers and submissions for pharmaceutical assets.
• Knowledge across health economics, epidemiology, biostatistics, systematic reviews and market access.
• Ability to collaborate across Access, Medical, HEOR and cross-functional or international teams.
• Strong written and verbal communication skills, sound judgment and a willingness to learn internal processes.
• Demonstrated action orientation, collaboration, self-awareness and ability to optimize work processes.

Responsibilities

• Lead the development of optimal brand pricing strategies in collaboration with Global and Regional Pricing and Reimbursement teams and Brand Directors or Managers.
• Develop robust economic evidence and clear value messages to support timely listing and optimal national patient access for Novartis brands.
• Lead HTA submissions for assigned assets, working with cross-functional partners to support the overall Access strategy.
• Interpret payer research and the Canadian reimbursement environment to identify opportunities, barriers and stakeholder needs for asset launches.
• Develop high-quality evidence dossiers, submission strategies, plans and deliverables for Canadian HTA and pricing and reimbursement bodies, including Canada’s Drug Agency and INESSS.
• Partner with Access, Medical, International HEOR and other internal stakeholders to define contracting strategies for new and existing products.
• Develop product listing agreements and negotiation strategies in collaboration with Health Policy and Access colleagues.
• Coordinate internal processes and external partners, including procurement, vendor engagement and HEOR approval activities, to deliver evidence-generation work efficiently.

Skills

Health economics

HTA Canadian process

Pricing strategies

Cross-functional collaboration

Data analysis

Education

Advanced education in health economics, epidemiology, biostatistics, outcomes research

Job description

Novartis Canada is seeking a health economics and pricing expert to support country-level HTA, pricing and reimbursement strategies for Novartis brands in Canada. You will translate payer research into actionable insights and lead cross-functional submissions and negotiations to optimize patient access.

You will collaborate with Health Policy, Medical and international HEOR teams to develop listing agreements and evidence dossiers, ensuring timely listings and renewals. Hybrid Toronto location.